Mahoney David L's Form 4 filing
Corcept Therapeutics IncCORT · filed Aug 20, 2026
- Accession no.
- 0001193125-26-359255
- Filed
- Aug 20, 2026, 4:30 PM ET
- Trade date
- Aug 18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $12.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahoney David LCIK 0001224091 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | SSaleDisposed | −4,984 | $117.47F2 | −$585,478.45 | 1,232,161 | Indirect | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −91,167 | $118.24F3 | −$10,779,367.28 | 1,140,994 | Indirect | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −7,055 | $118.88F4 | −$838,710.39 | 1,133,939 | Indirect | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −400 | $119.64F5 | −$47,855.24 | 1,133,539 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
The power of attorney under which this form was signed is on file with the Commission.